1 / 12

Corporate Presentation January 2009

Corporate Presentation January 2009. Ithaka Life Sciences Ltd. Advisory & management business started in 2000 Commercialising life science technologies: Business creation & business plans Technical, IP & commercial review & due diligence Sourcing investment finance

saeran
Download Presentation

Corporate Presentation January 2009

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Corporate Presentation January 2009

  2. Ithaka Life Sciences Ltd • Advisory & management business started in 2000 • Commercialising life science technologies: • Business creation & business plans • Technical, IP & commercial review & due diligence • Sourcing investment finance • Project planning and management e.g. clinical trials • Interim management, coaching & mentoring • Facilitation service: commercial goals and planning • Strategic advice: development & implementation e.g. market mapping

  3. Ithaka Track Record • >100 assignments completed for >60 clients • 8 university spin-outs created and financed • >£20 million funding for clients • Venture capital, corporate deals and grants • Commercial & IP reviews, & market research undertaken for >20 organisations • Due diligence conducted for 9 investment funds • Strong expertise in drug discovery & development • Unrivalled network of contacts • Strategic alliance with Ruston Poole International

  4. Ithaka Board Paul Rodgers Axis Genetics, Pestax, AGC, Tate & Lyle Gavin Scott Duncan Hydron, ICI, Reckitt & Colman, Guinness etc. Kim Heyworth WHEB Ventures

  5. Ithaka Consultants • John AdairBiopharmaceutical R&D (Axis Genetics, Scotgen, Celltech, Searle) • Sue BuchananMarketing & business development (GeneMedix, PA Consulting, NHS etc.) • Richard CummingLife science product development & marketing (Amersham, GE Healthcare) • Malcolm RhodesLife science research commercialisation (Serologicals, Celltech, Pfizer etc.) • Bill PrimroseDrug discovery & development (PanTherix, SioKem etc.) • Mark TreherneDrug discovery & development (Xention, Pfizer etc.) • Paula WittelsMedical devices & diagnostics (Pfizer, Quintiles etc.) • Grahaem BrownClinical research (UCB Celltech, Pfizer, Novartis etc.)

  6. Ithaka: Recent Corporate Clients

  7. Ithaka: University Clients

  8. Technologies Cell therapy Therapeutic proteins & peptides Vaccines Biomarkers Natural products Genomics & proteomics Sensors Diagnostics Medical devices Fermentation & bioprocessing In silico molecular modelling Markets Drug discovery & development Oncology, endocrine disorders, inflammatory, infectious & metabolic disease Wound healing Nutraceuticals & phytomedicines In vitro diagnostics Agrochemicals Plant breeding Fine chemicals Technologies and Markets

  9. Typical Assignments • Business creation & sourcing finance • Psynova Neurotech & Smart Holograms • Technical, commercial and market evaluation • e2v biosensors: rapid protein analysis • Selective Antibodies: small molecule immunoassays • Due diligence • NVM (Gentronix), YFM (Plasticell) & NESTA (Cytox) • Strategic advice • OneNorth East, Smith & Nephew • Interim management, mentoring & coaching • e2v biosensors, deltaDOT, Theryte, CRB & Crossgen • Facilitation • Scottish Enterprise Proof of Concept Fund

  10. Case Study: Smart Holograms • Novel hologram sensor technology • Potential applications in medical, environment and industrial sectors • Ithaka role • Commercial strategy, IP audit, business plan and finance • Paul Rodgers: interim CEO then chairman • Results • University spin-out company 2002 • Focus on healthcare diagnostics • £750k seed funding (including corporate deal) • £8M Series A funding in 2004/5 at £17M valuation • University Challenge Fund: 3-fold return on investment • Three blue chip corporate partners • First product launch in 2008 • Current valuation £80M

  11. Case Study: e2v biosensors • Wholly owned subsidiary of e2v technologies plc (LSE - £200M turnover) • Novel immunoassay technology • Potential applications in medical, life science R&D, pharma R&D, biodefence and food sectors • Ithaka role • Independent market assessment & development of commercial strategy • Team of 5 consultants deployed • Results • Focus on point of care diagnostics – rapid, ultrasensitive test for Troponin recommended for first product • Paul Rodgers appointed as CEO • Business plan • £850k budget for current financial year secured

  12. Why Work with Ithaka? • Personal experience • Technology commercialisation • New ventures • Fund raising • Growth through strategic partnerships • Across the life science spectrum • Multi-disciplinary team approach • Unique network of contacts • Support tailored to meet the evolving needs of a growing business

More Related